# T-Therapeutics funding rounds and investors

As of 5 Nov 2026, T-Therapeutics has raised $192.8M across 2 verified rounds on record (amounts in other currencies converted to USD); latest: $133 million Series B led by Advent Life Sciences and British Business Bank, announced 5 Nov 2026.

A biotechnology company developing next-generation T cell receptor (TCR) T cell engager (TCE) therapeutics for cancer and autoimmune diseases

Website: https://t-therapeutics.com/  
Headquarters: Cambridge, UK  
Page: https://fireround.dev/companies/t-therapeutics.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-11-05 | Series B | $133 million | Advent Life Sciences, British Business Bank | BGF, Cambridge Innovation Capital, Digitalis Ventures, Eli Lilly, F-Prime Capital, Johnson & Johnson Innovation – JJDC, M Ventures, Samsara BioCapital, Sanofi Ventures, Sofinnova Partners, Tencent | [globenewswire.com](https://www.globenewswire.com/news-release/2026/11/05/3396064/0/en/t-therapeutics-announces-oversubscribed-133-million-series-b-financing-to-achieve-clinical-proof-of-concept-for-first-in-class-tcr-bispecific-therapies-in-cancer-and-autoimmune-dis.html), [fiercebiotech.com](https://www.fiercebiotech.com/biotech/t-therapeutics-raises-133m-series-b-bispecific-pipeline-big-pharma-backers-tow), [european-biotechnology.com](https://european-biotechnology.com/latest-news/t-therapeutics-raises-133m-to-bring-tcr-bispecifics-into-clinic) |
| 2023-11-15 | Series A | £48 million ($59 million) | Cambridge Innovation Capital, Digitalis Ventures, F-Prime Capital, Sofinnova Partners | Sanofi Ventures, University of Cambridge | [t-therapeutics.com](https://t-therapeutics.com/t-therapeutics-raises-48-million-series-a-for-development-of-next-generation-tcr-therapeutics-to-transform-cancer-treatment), [sofinnovapartners.com](https://sofinnovapartners.com/news/t-therapeutics-raises-gbp48-million-series-a) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.